532 related articles for article (PubMed ID: 15772895)
1. The NMDA receptor complex: a long and winding road to therapeutics.
Wood PL
IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
[TBL] [Abstract][Full Text] [Related]
2. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
3. [Role of excitatory amino acids in neuropathology].
Wikinski SI; Acosta GB
Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
[TBL] [Abstract][Full Text] [Related]
6. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
Smith PF
Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain.
Long KD; Mastropaolo J; Rosse RB; Manaye KF; Deutsch SI
Brain Res Bull; 2006 May; 69(6):626-30. PubMed ID: 16716829
[TBL] [Abstract][Full Text] [Related]
10. [The role of the NMDA-receptor blocker and stimulator ketamine and glycine in the development of a neuropathic pain syndrome].
Danilova EI; Grafova VN; Reshetniak VK
Eksp Klin Farmakol; 1997; 60(4):10-3. PubMed ID: 9376747
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
[TBL] [Abstract][Full Text] [Related]
12. Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats.
Wiley JL; Balster RL
Life Sci; 2004 May; 75(2):141-51. PubMed ID: 15120567
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and the glutamate NMDA receptor.
Doraiswamy PM
Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
[TBL] [Abstract][Full Text] [Related]
14. Glutamate- and GABA-based CNS therapeutics.
Foster AC; Kemp JA
Curr Opin Pharmacol; 2006 Feb; 6(1):7-17. PubMed ID: 16377242
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the human NMDA receptor subunit NR3A glycine binding site.
Nilsson A; Duan J; Mo-Boquist LL; Benedikz E; Sundström E
Neuropharmacology; 2007 Mar; 52(4):1151-9. PubMed ID: 17320117
[TBL] [Abstract][Full Text] [Related]
16. Glutamate-based therapeutic approaches: inhibitors of glycine transport.
Lechner SM
Curr Opin Pharmacol; 2006 Feb; 6(1):75-81. PubMed ID: 16376148
[TBL] [Abstract][Full Text] [Related]
17. Putative NMDA receptors in Hydra: a biochemical and functional study.
Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
[TBL] [Abstract][Full Text] [Related]
18. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
Wafford KA; Kathoria M; Bain CJ; Marshall G; Le Bourdellès B; Kemp JA; Whiting PJ
Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
